Loading...
4CPS-121 Impact of pharmaceutical consultations for new oral oncology agents
BACKGROUND: Pharmaceutical consultations are organised in the Department of Oncology when new oral anticancer drugs are prescribed. Drug-drug interactions (DDI) and drug-food interactions are frequent with these new drugs and can produce serious adverse events (SAE). Due to the chronicity of the dis...
Na minha lista:
| Udgivet i: | Eur J Hosp Pharm |
|---|---|
| Main Authors: | , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Group
2018
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535313/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.212 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|